Further suppression of immune response in renal allograft recipients infected with hepatitis C.
Rao
V K
VK
University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Plummer
M
M
Khanna
A
A
D000367:Age Factors; D015703:Antigens, CD / Q000276:immunology; D017252:CD3 Complex / Q000276:immunology; D016022:Case-Control Studies; D003208:Concanavalin A / Q000494:pharmacology; D006526:Hepatitis C / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D007371:Interferon-gamma / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D010835:Phytohemagglutinins / Q000494:pharmacology; D012016:Reference Values; D012737:Sex Factors; D013601:T-Lymphocytes / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D015703:Antigens, CD; D017252:CD3 Complex; D010835:Phytohemagglutinins; D014409:Tumor Necrosis Factor-alpha; D003208:Concanavalin A; D007371:Interferon-gamma